Coughlin, C. A., Chahar, D., Lekakis, M., Youssfi, A. A., Li, L., Roberts, E., . . . Schatz, J. H. Bruton’s tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax. Nature Publishing Group.
Chicago Style (17th ed.) CitationCoughlin, Caroline A., et al. Bruton’s Tyrosine Kinase Inhibition Re-sensitizes Multidrug-resistant DLBCL Tumors Driven by BCL10 Gain-of-function Mutants to Venetoclax. Nature Publishing Group.
MLA (9th ed.) CitationCoughlin, Caroline A., et al. Bruton’s Tyrosine Kinase Inhibition Re-sensitizes Multidrug-resistant DLBCL Tumors Driven by BCL10 Gain-of-function Mutants to Venetoclax. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.